News & Updates

Alberta Changes 2nd COVID-19 Vaccine Dose Guidelines

Alberta approves 21 or 28 day COVID-19 vaccine interval for cancer patients on active treatment

Joint Cancer Action on the Second Dose of the COVID-19 Vaccine

Lymphoma Canada, Myeloma Canada, Save Your Skin Foundation and Lung Cancer Canada ask the Provincial Governments for timely administration of second COVID-19 vaccines for immunocompromised patients, prioritization of the vaccine for household members of patients receiving immunosuppressive therapy, and increased guidance on the COVID-19 vaccine specific for cancer patients.

Global Lung Cancer Coalition Patient Experience Survey

Join lung cancer patients around the world who are sharing their experience of lung cancer care.

New COVID-19 Vaccine Recommendations for Cancer Patients

New Ontario VCAG recommendations for COVID-19 vaccine intervals for cancer patients.

What's New In: Immunotherapy

A panel discussion of the latest advances in immunotherapy for the treatment of lung cancer. Featuring Dr. Julie Brahmer and Dr. Rosalyn Juergens. Moderated by Dr. Paul Wheatley-Price.

COVID-19 Vaccine Information for Lung Cancer Patients

Get answers to your questions and links to provincial rollout plans 

Webinar: What's New from CLCCO

Dr. Justin Gainor and Dr. Cheryl Ho discuss what's new from the Canadian Lung Cancer Conference. Moderated by Dr. Paul Wheatley-Price. 

Lung Cancer and Equity: A Focus on Income and Geography

A new report from CPAC and follow up Lung Cancer Voices podcast!

Displaying results 11-20 (of 92)
 |<  <  1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10  >  >|